Indicative syllabus information
INTRODUCTION
Need for health economics. What is an economic evaluation? Economic concepts: choice, scarcity, opportunity cost, allocative and technical efficiency; types of economic evaluation (design / economic question). National Institute of Clinical and Care Excellence (NICE) Methods guide / Reference case.
COST
Identification, valuation and measurement; non-market items; cost vs charges; average and marginal cost distinction; opportunity cost; indirect costs and approaches to measurement; overheads; perspective; data collection.
OUTCOMES: MONETARY
History of Cost Benefit Analysis (CBA); willingness to pay; willingness to accept; elicitation; discrete choice models.
OUTCOMES: SUBJECTIVE
Defining utility; measurement; standard gamble, time tradeoff, rating scale; Quality Adjusted Life Years (QALYs); questionnaire elicitation, EuroQol- 5 Dimensions (EQ-5D); who’s value and perspective; equity and QALYs.
OUTCOMES: CLINICAL
Outcome measurement; clinical measures; Health Related Quality of Life (HRQoL); disease specific; Short Form 36 (SF36); incremental approach; psychometrics (acceptability, validity, etc); mapping.
ANALYSIS
Incremental Cost Effectiveness Ratio (ICERs); cost effectiveness planes; uncertainty, bootstrapping, cost effectiveness acceptability curves; sensitivity analysis, boundaries, confidence intervals; time, discounting, costs/outcomes.
SYSTEMATIC REVIEWS & MODELLING
Alternatives to Randomised Controlled Trial (RCTs); Systematic reviews, what they are and why, their role in economic evaluation; Modelling, what is it, why, types e.g. decision trees / Markov modelling.
CRITICAL APRAISAL
How is economic evidence used in decisions? How can the quality of economic evidence be assured? What are the obstacles to appropriate use of evidence?
Critical appraisal of real economic evaluation studies / reporting standards.